The Appeals Court ruling affirmed the September 30, 2015 decision reached by the United States District Court for the Northern District of Illinois upholding Cumberland's patent and expressly
Prior to this synthetic route, bryostastin-1 had to be isolated from tons of natural sources to obtain grams of the drug. Bryostatin-1 is a complex marine natural product
It will leverage Enteris’ proprietary and patented oral peptide and small molecule delivery platform, Peptelligence, to engineer an oral formulation of a peptide-based injectable therapeutic developed by Ferring.
The Company has now dosed their first human subject with KM-819, an orally active small molecule that is a potentially disease-modifying treatment of Parkinson's Disease. The trial is
Charles Rowland, Chief Executive Officer of Aurinia, said: “Selecting a CRO for AURORA is a key milestone for Aurinia following our successful end-of-Phase 2 meeting with the U.S.
The financing was led by the Global Health Sciences Fund of Quark Venture and GF Securities, along with Mesa Verde Venture Partners. Existing Biscayne Pharmaceuticals investors and new
The total seed financing includes proceeds of CHF 0.5 million Seed A and CHF 2.3 million Seed B financing rounds conducted during 2016 and the proceeds of the
The transaction expands Celgene's Inflammation and Immunology pipeline through the acquisition of Delinia's lead program, DEL106, as well as related second generation programs. DEL106 is a novel IL-2
The newly approved dose will provide physicians with dosing flexibility based on individual presentation or tolerability, in treating the large and heterogenous population of adult CIC patients. The
The trial achieved its primary endpoint by meeting the statistical criteria for non-inferiority of overall survival with lenvatinib compared to sorafenib, the current standard of care for systemic
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.